Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Altitude Adaptation: A Glimpse Through Various Lenses
2015
Cellular and Molecular Mechanisms Associated with Carotid Body Adaptations to Chronic Hypoxia
2005
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Genetic Ablation of the Fatty Acid–Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis
2013
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2019
2019 Standout
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
2010
Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
2015 StandoutNobel
Pulmonary hypertension in chronic obstructive pulmonary disease
2003
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
2013 StandoutNobel
In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium
1992
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
The Spliceosome: Design Principles of a Dynamic RNP Machine
2009 Standout
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
2012
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
2020
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
1991
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
2013
Cardiac function in smokers and nonsmokers: The CARDIA study
1995
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Primary Pulmonary Hypertension
1997 Standout
The role of resistance in HCV treatment
2012
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
2012
Induction of angiogenesis during the transition from hyperplasia to neoplasia
1989 StandoutNature
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders
2011
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
2012
Glia-like Stem Cells Sustain Physiologic Neurogenesis in the Adult Mammalian Carotid Body
2007
Antiviral strategies in hepatitis C virus infection
2012
Oesophageal carcinoma
2013 Standout
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
2010 StandoutNature
Spliceosome disassembly catalyzed by Prp43 and its associated components Ntr1 and Ntr2
2005
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The Metabolic Basis of Pulmonary Arterial Hypertension
2014
Neurotoxic in vivo models of Parkinson’s disease
2010
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Atherosclerosis — An Inflammatory Disease
1999 Standout
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer
2011
Peripheral Chemoreceptors: Function and Plasticity of the Carotid Body
2012
Metastatic colonization by circulating tumour cells
2016 StandoutNature
What Are the Promising New Therapies in the Field of Chronic Hepatitis C After the First-Generation Direct-Acting Antivirals?
2012
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Carotid body mechanisms in acclimatization to hypoxia
2000
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Coexistent pulmonary and portal hypertension: Morphologic and clinical features
1987
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Mechanisms of acute oxygen sensing by the carotid body: Lessons from genetically modified animals
2007
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Biological Chemistry of Carbon Monoxide
2002
Acetylcholine and Bradykinin Relax Intrapulmonary Arteries by Acting on Endothelial Cells: Role in Lung Vascular Diseases
1981 Science
Peripheral chemoreceptors in health and disease
2004
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation
1983 StandoutNatureNobel
Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress.
1983
Phenotypic Heterogeneity of the Endothelium
2007
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
The Emergence of Methicillin-Resistant Staphylococcus aureus Infections in United States Hospitals
1982
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
PHD2 inactivation in Type I cells drives HIF‐2α‐dependent multilineage hyperplasia and the formation of paraganglioma‐like carotid bodies
2018 StandoutNobel
Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical Patients
2006
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Hidden fluid mechanics: Learning velocity and pressure fields from flow visualizations
2020 StandoutScience
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
2019 StandoutNobel
Carotid body hyperplasia in cystic fibrosis and cyanotic heart disease. A combined morphometric, ultrastructural, and biochemical study.
1985
Antimicrobial resistance of Staphylococcus aureus: genetic basis
1987
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
2013
Capillary endothelial cell cultures: phenotypic modulation by matrix components.
1983
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis
1997
Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci
1985
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
2012
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
The Crisis in Antibiotic Resistance
1992 StandoutScience
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.
1989
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features
1979
Chief cell hyperplasia in the human carotid body at high altitudes: Physiologic and pathologic significance
1976
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
2014
Methicillin-resistant staphylococci
1988
Effects of Nifedipine on Ventilation/Perfusion Matching in Primary Pulmonary Hypertension
1983
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Global cancer statistics, 2012
2015 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Primary Pulmonary Hypertension
1993
Primary Pulmonary Hypertension: Radiographic and Scintigraphic Patterns of Histologic Subtypes
1986
New therapeutic strategies in HCV: second‐generation protease inhibitors
2013
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
2011
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Patrick F. Smith being referenced
Impact of Low-Dose Ritonavir on Danoprevir Pharmacokinetics
2012
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study
2010
Histopathology of the carotid bodies in neonates and infants
1990
The ultrastructure of plexogenic pulmonary arteriopathy
1990
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia
2003
Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C
2012
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
2010
Effect of Tenofovir Disoproxil Fumarate on the Pharmacokinetics and Pharmacodynamics of Total, R‐, and S‐Methadone
2004
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
2011
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
2005
A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors
2007
Mast cells in the human carotid body.
1987
Electron microscopy of the plexiform lesion.
1979
Endothelial cell pavement pattern in the pulmonary trunk in rats in chronic hypoxia
1980
Small pulmonary arteries in some natives of La Paz, Bolivia.
1981
Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal Cancer
2002
Pulmonary Vascular Disease
1977
The pathology of the early and late stages of primary pulmonary hypertension.
1987
Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
2016
62 ACTIVITY OF DANOPREVIR PLUS LOW-DOSE RITONAVIR (DNV/R) IN COMBINATION WITH PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN (PEGIFNa-2A/RBV) IN PREVIOUS NULL RESPONDERS
2011
Pulmonary hypertension complicating portal vein thrombosis.
1979
Dosing will be a key success factor in repurposing antivirals for COVID‐19
2020
Hyperplasia of the carotid body
1982
Paraquat
1976
The influence of age and sex on the response of the right ventricle, pulmonary vasculature and carotid bodies to hypoxia in rats
1974
Anatomical variation and quantitative histology of the normal and enlarged carotid body
1982
Interaction between a G-Patch Protein and a Spliceosomal DEXD/H-Box ATPase That Is Critical for Splicing
2004
The atherosclerotic human carotid sinus
1973
Electron microscopy of hypertensive pulmonary vascular disease
1983
Optimizing COVID‐19 Candidate Therapeutics: Thinking Without Borders
2020
Pulmonary endothelial pavement patterns.
1980
Differential methicillin susceptibilities of peptidoglycan syntheses in methicillin-resistant Staphylococcus aureus
1981
Comparative pathology of the enlarged carotid body
1985
The histology of the carotid bodies in highlanders from Ladakh
1988
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude
1973
Ultrastructure of hypoxic hypertensive pulmonary vascular disease
1977
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression
2008